Wells Fargo’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,000
| Closed | -$4.04K | – | 7166 |
|
|
2025
Q1 | $4.04K | Hold |
1,000
| – | – | ﹤0.01% | 6056 |
|
|
2024
Q4 | $3.2K | Hold |
1,000
| – | – | ﹤0.01% | 6128 |
|
|
2024
Q3 | $2.24K | Sell |
1,000
-2,000
| -67% | -$4.62K | ﹤0.01% | 6043 |
|
|
2024
Q2 | $6.45K | Sell |
3,000
-159
| -5% | -$283 | ﹤0.01% | 5830 |
|
|
2024
Q1 | $6.48K | Sell |
3,159
-13,979
| -82% | -$27.9K | ﹤0.01% | 5846 |
|
|
2023
Q4 | $39.2K | Buy |
17,138
+999
| +6% | +$2.17K | ﹤0.01% | 5363 |
|
|
2023
Q3 | $27.4K | Buy |
16,139
+8,243
| +104% | +$18.7K | ﹤0.01% | 5468 |
|
|
2023
Q2 | $19.5K | Buy |
7,896
+6,018
| +320% | +$16.4K | ﹤0.01% | 5747 |
|
|
2023
Q1 | $4.23K | Buy |
1,878
+1,829
| +3,733% | +$9.18K | ﹤0.01% | 6093 |
|
|
2022
Q4 | $250 | Buy |
49
+1
| +2% | +$7 | ﹤0.01% | 6554 |
|
|
2022
Q3 | $0 | Buy |
48
+2
| +4% | +$24 | ﹤0.01% | 6723 |
|
|
2022
Q2 | $0 | Sell |
46
-138
| -75% | -$1.81K | ﹤0.01% | 6862 |
|
|
2022
Q1 | $3K | Buy |
184
+145
| +372% | +$3.11K | ﹤0.01% | 6570 |
|
|
2021
Q4 | $1K | Buy |
39
+1
| +3% | +$33 | ﹤0.01% | 6977 |
|
|
2021
Q3 | $1K | Sell |
38
-2
| -5% | -$59 | ﹤0.01% | 6671 |
|
|
2021
Q2 | $1K | Sell |
40
-4,945
| -99% | -$137K | ﹤0.01% | 6631 |
|
|
2021
Q1 | $157K | Sell |
4,985
-8,758
| -64% | -$294K | ﹤0.01% | 5271 |
|
|
2020
Q4 | $364K | Buy |
13,743
+1,423
| +12% | +$36K | ﹤0.01% | 4751 |
|
|
2020
Q3 | $330K | Buy |
12,320
+976
| +9% | +$23.4K | ﹤0.01% | 4649 |
|
|
2020
Q2 | $224K | Buy |
11,344
+7,520
| +197% | +$137K | ﹤0.01% | 4838 |
|
|
2020
Q1 | $57K | Sell |
3,824
-76
| -2% | -$1.34K | ﹤0.01% | 5289 |
|
|
2019
Q4 | $67K | Buy |
3,900
+1
| +0% | +$17 | ﹤0.01% | 5424 |
|
|
2019
Q3 | $97K | Buy |
3,899
+3,882
| +22,835% | +$107K | ﹤0.01% | 5331 |
|
|
2019
Q2 | $1K | Buy |
+17
| New | +$667 | ﹤0.01% | 6235 |
|
Wells Fargo's CKPT Position: Q2 2025 in Review
Wells Fargo sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 1,000 shares — an estimated $4.04K sold.
Wells Fargo first reported a position in CKPT in Q2 2019 and held it in 24 quarters. The position peaked at $364K in Q4 2020. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.
- Wells Fargo reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
- Wells Fargo sold 1,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $4.04K.
- Wells Fargo first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 24 quarters.
- Wells Fargo's Checkpoint Therapeutics position peaked at $364K in Q4 2020.
- 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.
Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.